Literature DB >> 18678658

Serial isolates of persistent Haemophilus influenzae in patients with chronic obstructive pulmonary disease express diminishing quantities of the HMW1 and HMW2 adhesins.

Deborah M Cholon1, David Cutter, Stephen K Richardson, Sanjay Sethi, Timothy F Murphy, Dwight C Look, Joseph W St Geme.   

Abstract

In patients with chronic obstructive pulmonary disease (COPD), the lower respiratory tract is commonly colonized by bacterial pathogens, including nontypeable Haemophilus influenzae. The H. influenzae HMW1 and HMW2 adhesins are homologous proteins that promote bacterial adherence to respiratory epithelium and are the predominant targets of the host immune response. These adhesins undergo graded phase variation, controlled by the numbers of 7-bp repeats upstream of the HMW1 and HMW2 structural genes (hmw1A and hmw2A, respectively). In this study, we examined the levels of HMW1 and HMW2 expressed by H. influenzae isolates collected serially from patients with COPD. We found that expression of HMW1 and HMW2 in a given strain decreased over time in a majority of patients, reflecting progressive increases in the numbers of 7-bp repeats and associated with high serum titers of HMW1/HMW2-specific antibodies. We speculate that the presence of high titers of antibodies against the HMW1 and HMW2 adhesins and other immune factors in the lower respiratory tracts of patients with COPD may result in gradual selection for bacteria with reduced levels of HMW1 and HMW2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678658      PMCID: PMC2546813          DOI: 10.1128/IAI.00499-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion.

Authors:  Joseph W St Geme
Journal:  Cell Microbiol       Date:  2002-04       Impact factor: 3.715

2.  Evolutionary and functional relationships among the nontypeable Haemophilus influenzae HMW family of adhesins.

Authors:  Amy Z Buscher; Katie Burmeister; Stephen J Barenkamp; Joseph W St Geme
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

3.  The pathogenicity of Haemophilus influenzae.

Authors:  D C Turk
Journal:  J Med Microbiol       Date:  1984-08       Impact factor: 2.472

4.  Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.

Authors:  Cecilia L Chin; Lori J Manzel; Erin E Lehman; Alicia L Humlicek; Lei Shi; Timothy D Starner; Gerene M Denning; Timothy F Murphy; Sanjay Sethi; Dwight C Look
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

5.  Haemophilus influenzae adheres to and enters cultured human epithelial cells.

Authors:  J W St Geme; S Falkow
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media.

Authors:  S J Barenkamp; F F Bodor
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

7.  Evidence for conservation of architecture and physical properties of Omp85-like proteins throughout evolution.

Authors:  Neeraj K Surana; Susan Grass; Gail G Hardy; Huilin Li; David G Thanassi; Joseph W St Geme
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

8.  Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Andrew T Schiffmacher; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

9.  The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis.

Authors:  Susan Grass; Amy Z Buscher; W Edward Swords; Michael A Apicella; Stephen J Barenkamp; Neil Ozchlewski; Joseph W St Geme
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

10.  Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae.

Authors:  Carina A Rodriguez; Vasanthi Avadhanula; Amy Buscher; Arnold L Smith; Joseph W St Geme; Elisabeth E Adderson
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  16 in total

1.  Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.

Authors:  Mohamed Alamro; Fadil A Bidmos; Hannah Chan; Neil J Oldfield; Emma Newton; Xilian Bai; Jack Aidley; Rory Care; Claire Mattick; David P J Turner; Keith R Neal; Dlawer A A Ala'aldeen; Ian Feavers; Ray Borrow; Christopher D Bayliss
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

3.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

4.  Prevalence, distribution, and sequence diversity of hmwA among commensal and otitis media non-typeable Haemophilus influenzae.

Authors:  Gregg S Davis; May Patel; James Hammond; Lixin Zhang; Suzanne Dawid; Carl F Marrs; Janet R Gilsdorf
Journal:  Infect Genet Evol       Date:  2014-10-05       Impact factor: 3.342

5.  Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.

Authors:  Melinda M Pettigrew; Christian P Ahearn; Janneane F Gent; Yong Kong; Mary C Gallo; James B Munro; Adonis D'Mello; Sanjay Sethi; Hervé Tettelin; Timothy F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

6.  Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

7.  Phase variation and host immunity against high molecular weight (HMW) adhesins shape population dynamics of nontypeable Haemophilus influenzae within human hosts.

Authors:  Gregg S Davis; Simeone Marino; Carl F Marrs; Janet R Gilsdorf; Suzanne Dawid; Denise E Kirschner
Journal:  J Theor Biol       Date:  2014-04-18       Impact factor: 2.691

8.  In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis.

Authors:  Iris De Schutter; Alexandra Dreesman; Oriane Soetens; Marc De Waele; Françoise Crokaert; Jan Verhaegen; Denis Piérard; Anne Malfroot
Journal:  BMC Pediatr       Date:  2012-06-22       Impact factor: 2.125

9.  Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection.

Authors:  Ariadna Fernández-Calvet; Begoña Euba; Celia Gil-Campillo; Arancha Catalan-Moreno; Javier Moleres; Sara Martí; Alexandra Merlos; Jeroen D Langereis; Francisco García-Del Portillo; Lauren O Bakaletz; Garth D Ehrlich; Eric A Porsch; Margarita Menéndez; Joshua C Mell; Alejandro Toledo-Arana; Junkal Garmendia
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

10.  A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.

Authors:  John M Atack; Yogitha N Srikhanta; Kate L Fox; Joseph A Jurcisek; Kenneth L Brockman; Tyson A Clark; Matthew Boitano; Peter M Power; Freda E-C Jen; Alastair G McEwan; Sean M Grimmond; Arnold L Smith; Stephen J Barenkamp; Jonas Korlach; Lauren O Bakaletz; Michael P Jennings
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.